К содержанию
РецензированоEN2022

Molecular genetic markers and metabolic disorders in non-alcoholic fatty liver disease

A.B. Krivosheev · V.N. Maksimov · K.Yu. Boyko · E.E. Levykina · E.S. Mikhaylova · N.A. Varaksin · M.A. Kondratova · I.A. Krivosheeva · A.I. Autenshlyus

Научные статьи · 2022

Аннотация

Aim: to assess the probability of unfavorable outcomes of non-alcoholic fatty liver disease (NAFLD) based on clinical, biochemical, and molecular genetic parameters. Patients and Methods: 440 individuals were examined. Among them, 115 patients (84 men and 31 women) aged 23–69 (mean 49.3±1.1 years) were diagnosed with NAFLD and 325 healthy volunteers (172 men and 153 women) aged 25–67 (mean age 47.9±0.6 years) were controls.

Доказательный фрагмент

«Aim: to assess the probability of unfavorable outcomes of non-alcoholic fatty liver disease (NAFLD) based on clinical, biochemical, and molecular genetic parameters.»

Образец извлечения

Демо-превью

Aim: to assess the probability of unfavorable outcomes of non-alcoholic fatty liver disease (NAFLD) based on clinical, biochemical, and molecular genetic parameters. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники